Anders Rabbe, CEO

CEO since October 2020. Bachelor of Science in business administration from Webster University, Genève. Anders has been the CEO of several companies within the biotech and the financial sector. The last 10 years, until November 2019, Anders has held the position as CEO of Isofol Medical AB (publ). He is a board member of Nanologica AB and Baricol Bariatrics AB.